Acupuncture therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials

Fibromyalgia is a medical condition that affects millions of people worldwide, characterized by widespread, persistent musculoskeletal pain. This syndrome can cause significant fatigue, sleep difficulties, cognitive problems, and mood changes, severely impacting patients' quality of life. Fibromyalgia primarily affects middle-aged women and represents a major challenge both for those who suffer from the condition and for the healthcare professionals seeking effective treatments. From an economic standpoint, the disease generates substantial costs for healthcare systems and considerable productivity losses.

Traditional pharmacological treatments, such as tricyclic antidepressants and anticonvulsants, often offer only modest benefits and can entail unwanted side effects, leading many patients to seek complementary therapeutic alternatives.

The present study is a systematic review and meta-analysis that aimed to evaluate the efficacy and safety of acupuncture in the treatment of fibromyalgia. The researchers conducted a comprehensive search in multiple electronic databases, including PubMed, the Cochrane Library, Embase, and Chinese databases, covering publications through May 2018. The methodology rigorously followed guidelines established by the Cochrane Collaboration, using specific inclusion criteria that included only randomized controlled trials comparing real acupuncture with sham acupuncture or conventional medications. The researchers included both manual acupuncture and electroacupuncture but excluded techniques such as dry needling that did not follow the principles of traditional Chinese medicine.

To assess the methodological quality of the studies, they used the Cochrane risk of bias assessment tool, and the quality of evidence was rated using the GRADE system.

Of the 744 studies initially identified, only 12 randomized controlled trials met the inclusion criteria, totaling 528 participants. The meta-analysis revealed encouraging results for the use of acupuncture in the treatment of fibromyalgia. Regarding pain relief measured by the visual analog scale, real acupuncture demonstrated statistically significant superiority compared with sham acupuncture, with a mean difference of 1.04 points on a 0 to 10 scale. This improvement was maintained both in the short term and at long-term follow-up.

As for quality of life assessed through the Fibromyalgia Impact Questionnaire, patients treated with real acupuncture also showed substantial improvements compared with those who received sham acupuncture. Subgroup analyses showed that both manual acupuncture and electroacupuncture were effective for short-term pain reduction, although manual acupuncture demonstrated more consistent benefits in the long term. Regarding safety, no serious adverse events were reported, with only mild side effects observed, such as small hematomas, tenderness at the application site, or temporary discomfort.

The findings of this research have important implications for both patients and healthcare professionals. For patients living with fibromyalgia, the results suggest that acupuncture can offer a safe and effective therapeutic option, especially considering the limitations of conventional pharmacological treatments. Acupuncture may be particularly valuable for patients who have experienced intolerable side effects with traditional medications or who prefer non-pharmacological therapeutic approaches. For healthcare professionals, these findings provide moderate- to low-quality scientific evidence that may guide clinical decisions about incorporating acupuncture into multidisciplinary treatment plans for fibromyalgia.

It is important to note that acupuncture should not be seen as a complete replacement for other established treatments, but as an integral part of a comprehensive therapeutic approach that may include exercise, patient education, behavioral therapy, and, when appropriate, medications.

However, it is essential to recognize the important limitations of this study. The relatively small number of clinical trials included and the sample sizes of the individual studies limit the precision of the evidence. The considerable heterogeneity observed across studies, possibly due to differences in acupuncture point selection, sham acupuncture methods, and treatment protocols, reduces confidence in generalizing the results. In addition, few studies included extended follow-up periods, limiting our understanding of the lasting effects of acupuncture.

The variable methodological quality of the included studies also represents a limitation, with some showing a high risk of bias. Finally, it is important that patients interested in acupuncture seek qualified and licensed practitioners, and maintain open dialogue with their medical team about all therapies they are considering or using. Future studies with larger samples, more rigorous methodology, and long-term follow-up will be essential to strengthen the evidence base and define optimal acupuncture treatment protocols for fibromyalgia.